DexCom, Inc.
DexCom, Inc. price
About DexCom, Inc.
DexCom, Inc. on lääketieteellisen teknologian yritys, joka keskittyy ensisijaisesti jatkuvan glukoosin monitoroinnin (CGM) järjestelmien innovoimiseen, kehittämiseen ja markkinointiin. Yritys toimii Yhdysvalloissa ja kansainvälisesti ja tarjoaa ratkaisujaan diabeteksen hoitaville sekä terveydenhuollon ammattilaisille. Sen tuotevalikoimaan kuuluu DexCom G6, kattava CGM-järjestelmä diabeteksen hallintaan; Dexcom Real-Time API, joka mahdollistaa valtuutettujen kolmansien osapuolten kehittäjien integroida reaaliaikaisen CGM-datan digitaalisiin terveyssovelluksiinsa; Dexcom ONE, jonka tavoitteena on korvata perinteinen sormenpistoveren verensokeritestaus hoitopäätöksissä; sekä Dexcom Share, etäseurantaalusta. Yritys kehittää myös Dexcom G7:ää, seuraavan sukupolven CGM-järjestelmäänsä. Lisäksi DexCom, Inc:llä on lisenssi- ja yhteistyösopimus Verily Life Sciences LLC:n ja Verily Ireland Limitedin kanssa veripohjaisten tai interstitiaalisten glukoosin seurantatuotteiden kehittämiseksi. Yritys myy tuotteitaan suoraan erikoislääkäreille, kuten endokrinologeille, lääkäreille ja diabeteskouluttajille. DexCom, Inc. perustettiin vuonna 1999 ja sen pääkonttori sijaitsee San Diegossa, Kaliforniassa.
- Osaketunnus
- DXCM
- Yritys
- DexCom, Inc.
- Teollisuus
- Terveydenhuolto
- Kategoria
- US
- Osakeanti / osakeyhdistäminen
- 14
- Lanseerauspäivä
- 14.4.2005
- Listattu pörssi
- NASDAQ
Taloustiedot
Yhteenveto: DXCM reported Revenue of 1.31B (+13,08 %), beating expectations; EPS of 0,70 (+45,83 %), beating expectations.
Osingot
DexCom, Inc. conversion tables
| 0.5 DXCM | 38,28 EUR |
| 1 DXCM | 76,57 EUR |
| 5 DXCM | 382,88 EUR |
| 10 DXCM | 765,76 EUR |
| 0.5 EUR | 0,0065294 DXCM |
| 1 EUR | 0,013059 DXCM |
| 5 EUR | 0,065294 DXCM |
| 10 EUR | 0,13059 DXCM |
More to explore
FAQ
DXCM is trading at €76,58, +0,02 % over the last 24 hours. Track live moves on the price chart at the top of this page.
The DXCM stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. DXCM is currently trading at €76,58, +0,02 % over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on DXCM price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Terveydenhuolto sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. DXCM's P/E ratio is currently 34,01 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from DXCM; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against DXCM's historical range and other companies in the Terveydenhuolto sector.
DexCom, Inc.'s market cap is currently 28,89 mrd. EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.





















